617.20
price down icon4.86%   -31.53
after-market After Hours: 617.00 -0.20 -0.03%
loading
Idexx Laboratories Inc stock is traded at $617.20, with a volume of 628.72K. It is down -4.86% in the last 24 hours and down -14.84% over the past month. Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
See More
Previous Close:
$648.73
Open:
$651.49
24h Volume:
628.72K
Relative Volume:
1.18
Market Cap:
$49.28B
Revenue:
$4.30B
Net Income/Loss:
$1.06B
P/E Ratio:
47.20
EPS:
13.076
Net Cash Flow:
$1.04B
1W Performance:
-4.10%
1M Performance:
-14.84%
6M Performance:
-5.38%
1Y Performance:
+34.95%
1-Day Range:
Value
$616.13
$651.57
1-Week Range:
Value
$616.13
$651.57
52-Week Range:
Value
$356.14
$769.98

Idexx Laboratories Inc Stock (IDXX) Company Profile

Name
Name
Idexx Laboratories Inc
Name
Phone
(207) 556-0300
Name
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Name
Employee
11,000
Name
Twitter
@idexx
Name
Next Earnings Date
2026-02-02
Name
Latest SEC Filings
Name
IDXX's Discussions on Twitter

Compare IDXX vs TMO, DHR, A, WAT

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
617.20 51.80B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
509.82 198.06B 44.56B 6.73B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
214.94 155.50B 24.57B 3.60B 5.25B 5.0475
Diagnostics & Research icon
A
Agilent Technologies Inc
124.88 36.46B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
WAT
Waters Corp
319.83 32.29B 3.17B 642.63M 539.81M 10.77

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-09-25 Initiated Barclays Overweight
Oct-31-25 Upgrade Stifel Hold → Buy
Oct-01-25 Initiated UBS Neutral
Aug-05-25 Reiterated BTIG Research Buy
Jul-01-25 Initiated Jefferies Buy
Dec-02-24 Initiated Leerink Partners Outperform
Jul-25-24 Initiated BTIG Research Buy
Jan-30-24 Downgrade Piper Sandler Overweight → Neutral
Dec-07-23 Initiated Exane BNP Paribas Outperform
Dec-04-23 Upgrade Cleveland Research Neutral → Buy
Aug-02-23 Downgrade Atlantic Equities Overweight → Neutral
Jul-25-22 Downgrade Stifel Buy → Hold
Jul-21-22 Upgrade Goldman Neutral → Buy
Jul-12-22 Initiated Piper Sandler Overweight
May-05-22 Downgrade BofA Securities Buy → Neutral
Feb-08-22 Initiated Atlantic Equities Overweight
Nov-18-21 Initiated Morgan Stanley Overweight
Aug-05-21 Resumed Credit Suisse Outperform
Jul-12-21 Downgrade Guggenheim Buy → Neutral
Feb-17-21 Initiated Barclays Overweight
Sep-09-19 Initiated Goldman Neutral
May-23-19 Initiated Guggenheim Buy
Nov-02-18 Reiterated BofA/Merrill Buy
May-07-18 Reiterated Stifel Buy
Jan-16-18 Initiated Piper Jaffray Overweight
Aug-23-17 Upgrade BofA/Merrill Neutral → Buy
Jul-28-17 Upgrade CL King Neutral → Buy
Feb-03-17 Downgrade Feltl & Co. Hold → Sell
Sep-29-16 Resumed BofA/Merrill Neutral
Aug-16-16 Reiterated Stifel Buy
Aug-03-16 Upgrade Northcoast Sell → Neutral
Jul-20-16 Reiterated Canaccord Genuity Buy
Apr-19-16 Reiterated Canaccord Genuity Buy
Apr-01-16 Initiated CL King Neutral
Mar-21-16 Reiterated Stifel Buy
Feb-04-16 Initiated Credit Suisse Outperform
Oct-29-15 Reiterated Stifel Buy
Aug-28-15 Downgrade Raymond James Outperform → Mkt Perform
Aug-13-15 Reiterated Stifel Buy
Jul-23-15 Reiterated Canaccord Genuity Buy
View All

Idexx Laboratories Inc Stock (IDXX) Latest News

pulisher
07:15 AM

IDEXX Laboratories to Present at Two Institutional Investor Conferences - 01net

07:15 AM
pulisher
07:50 AM

4,049 Shares in IDEXX Laboratories, Inc. $IDXX Purchased by Krilogy Financial LLC - MarketBeat

07:50 AM
pulisher
07:48 AM

Rhumbline Advisers Reduces Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

07:48 AM
pulisher
Feb 11, 2026

IDEXX Laboratories Inc(IDXX.US) Officer Sells US$7.34 Million in Common Stock - 富途牛牛

Feb 11, 2026
pulisher
Feb 11, 2026

Insider Selling: IDEXX Laboratories (NASDAQ:IDXX) EVP Sells 11,345 Shares of Stock - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Baron Partners Fund is Leveraging IDEXX Laboratories’ (IDXX) Long-Term Growth Drivers - Insider Monkey

Feb 11, 2026
pulisher
Feb 11, 2026

IDEXX Laboratories, Inc. $IDXX Shares Sold by Jensen Investment Management Inc. - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Midwest Trust Co Purchases 12,179 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

IDEXX Laboratories, Inc. $IDXX Stock Position Decreased by RFG Advisory LLC - MarketBeat

Feb 11, 2026
pulisher
Feb 10, 2026

Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Aug Swings: Can IDEXX Laboratories Inc keep up with sector leadersJuly 2025 Breakouts & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Feb 10, 2026
pulisher
Feb 10, 2026

IDEXX Laboratories, Inc. $IDXX Shares Sold by ProShare Advisors LLC - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Candriam S.C.A. Has $14.68 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 10, 2026
pulisher
Feb 09, 2026

Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $750 - 富途牛牛

Feb 09, 2026
pulisher
Feb 09, 2026

Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating - marketscreener.com

Feb 09, 2026
pulisher
Feb 09, 2026

Oppenheimer Asset Management Inc. Sells 3,458 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 09, 2026
pulisher
Feb 08, 2026

State of Michigan Retirement System Lowers Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 08, 2026
pulisher
Feb 07, 2026

IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Finviz

Feb 07, 2026
pulisher
Feb 07, 2026

Envestnet Asset Management Inc. Trims Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

IDEXX Laboratories, Inc. $IDXX Shares Sold by IQ EQ FUND MANAGEMENT IRELAND Ltd - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

IDEXX Laboratories (NASDAQ:IDXX) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat

Feb 07, 2026
pulisher
Feb 06, 2026

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Qiagen (QGEN) and InnovAge Holding (INNV) - The Globe and Mail

Feb 06, 2026
pulisher
Feb 05, 2026

Is IDEXX’s Innovation-Fueled 2025 Results And 2026 Outlook Altering The Investment Case For IDXX? - Sahm

Feb 05, 2026
pulisher
Feb 05, 2026

Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating - marketscreener.com

Feb 05, 2026
pulisher
Feb 05, 2026

4 Analysts Have This To Say About IDEXX Laboratories - Benzinga

Feb 05, 2026
pulisher
Feb 05, 2026

IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market - Finviz

Feb 05, 2026
pulisher
Feb 05, 2026

Fidelity Growth Strategies Fund Avoids IDEXX Laboratories (IDXX) Due to Questionable Growth Durability - Insider Monkey

Feb 05, 2026
pulisher
Feb 05, 2026

BI Asset Management Fondsmaeglerselskab A S Has $28.77 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Bessemer Group Inc. Sells 29,560 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST) - The Globe and Mail

Feb 05, 2026
pulisher
Feb 04, 2026

Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850 - marketscreener.com

Feb 04, 2026
pulisher
Feb 04, 2026

Idexx Laboratories executive vice president sells $4.6 million in stock - MSN

Feb 04, 2026
pulisher
Feb 04, 2026

IDEXX: A Great Business Trapped By A Demanding Valuation (NASDAQ:IDXX) - Seeking Alpha

Feb 04, 2026
pulisher
Feb 04, 2026

Hantz Financial Services Inc. Decreases Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Alta Capital Management LLC Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Atlantic Union Bankshares Corp Takes Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

Rep. April McClain Delaney Sells Off Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Feb 04, 2026
pulisher
Feb 03, 2026

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY) - The Globe and Mail

Feb 03, 2026
pulisher
Feb 03, 2026

A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $730 to $805 - 富途牛牛

Feb 03, 2026
pulisher
Feb 03, 2026

IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results - Benzinga

Feb 03, 2026
pulisher
Feb 03, 2026

Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $775 - 富途牛牛

Feb 03, 2026
pulisher
Feb 03, 2026

Roku To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Feb 03, 2026
pulisher
Feb 03, 2026

Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830 - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

BTIG Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $800 - 富途牛牛

Feb 03, 2026
pulisher
Feb 03, 2026

UBS Adjusts IDEXX Laboratories PT to $730 From $750 - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 earnings call transcript - MSN

Feb 03, 2026
pulisher
Feb 03, 2026

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 03, 2026
pulisher
Feb 03, 2026

BTIG Adjusts Price Target on IDEXX Laboratories to $800 From $830 - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $655 From $700 - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

IDEXX Laboratories, Inc. $IDXX Shares Sold by Villere ST Denis J & Co. LLC - MarketBeat

Feb 03, 2026
pulisher
Feb 03, 2026

Thrivent Financial for Lutherans Has $38.68 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Feb 03, 2026

Idexx Laboratories Inc Stock (IDXX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research A
$124.88
price down icon 3.12%
diagnostics_research WAT
$319.83
price down icon 2.85%
$207.84
price down icon 2.18%
diagnostics_research IQV
$168.85
price down icon 4.70%
diagnostics_research MTD
$1,357.92
price down icon 2.49%
Cap:     |  Volume (24h):